Resistance to Targeted Therapies in Breast Cancer

• Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
• Άλλοι συγγραφείς: Prosperi, Jenifer R. (Επιμελητής έκδοσης)
• Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
• Γλώσσα: English
• Έκδοση: Cham : Springer International Publishing : Imprint: Springer, 2017.
• Σειρά: Resistance to Targeted Anti-Cancer Therapeutics, 16
• Θέματα: Medicine.; Cancer research.; Biomedicine.; Cancer Research.

We present an in-depth description of resistance to targeted therapies in breast cancer. Targeted therapies discussed here include those used to treat ER+ or Her2+ breast cancers (i.e., Tamoxifen or trastuzumab) or those targeting signaling pathways aberrantly activated in triple negative breast can...

Πίνακας περιεχομένων:

• Invasive Breast Cancer Therapy 2017: How Well Are We Hitting The Target?
• Resistance to HER2-targeted therapy
• Endocrine Resistance and Breast Cancer Stem Cells – The Inflammatory Connection That Could Lead to New and Improved Therapy Outcomes
• EGFR Resistance
• Targeting FGFR for the treatment of breast cancer
• Targeted Therapies in Breast Cancer
• Future paradigm of breast cancer resistance and treatment.